We are live on ! Find out more
CVA

Central Valley Advisors Portfolio holdings

AUM $390M
1-Year Est. Return 20.62%
This Fund
S&P 500
This Quarter Est. Return
+3.07%
1 Year Est. Return
+20.62%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$234M
AUM Growth
+$40.7M
Cap. Flow
-$18.9M
Cap. Flow %
-8.09%
Top 10 Hldgs %
47%
Holding
196
New
39
Increased
30
Reduced
54
Closed
59

Top Sells

Rank Stock Value
1
CLX icon
Clorox
CLX
+$1.5M
2
BKNG icon
Booking.com
BKNG
+$1.46M
3
CSCO icon
Cisco
CSCO
+$1.3M
4
KEYS icon
Keysight
KEYS
+$1.22M
5
DXCM icon
DexCom
DXCM
+$1.21M

Sector Composition

Rank Sector Weight
1 Healthcare 21.49%
2 Technology 16.51%
3 Financials 7.09%
4 Industrials 5.66%
5 Consumer Discretionary 4.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNP icon
26
Union Pacific
UNP
$174B
$2.42M 1.03%
8,389
+320
+4% +$75K
MRK icon
27
Merck
MRK
$322B
$2.34M 1%
16,916
+335
+2% +$43.2K
UAPR icon
28
Innovator US Equity Ultra Buffer ETF April
UAPR
$157M
$1.9M 0.81%
+27,482
New +$776K
HMOP icon
29
Hartford Municipal Opportunities ETF
HMOP
$777M
$1.89M 0.81%
49,765
+2,793
+6% +$108K
CRM icon
30
Salesforce
CRM
$151B
$1.89M 0.81%
6,159
+157
+3% +$42K
CB icon
31
Chubb
CB
$135B
$1.87M 0.8%
7,337
-1
-0% -$257
FANG icon
32
Diamondback Energy
FANG
$57.1B
$1.84M 0.79%
9,214
+124
+1% +$24.6K
STE icon
33
Steris
STE
$22.3B
$1.82M 0.78%
5,409
+220
+4% +$47.8K
HAL icon
34
Halliburton
HAL
$26.9B
$1.79M 0.76%
45,014
+1,837
+4% +$67.8K
IQV icon
35
IQVIA
IQV
$38.7B
$1.78M 0.76%
5,940
+328
+6% +$74.5K
FISV
36
Fiserv Inc
FISV
$28.8B
$1.77M 0.76%
11,138
+237
+2% +$35.9K
INTC icon
37
Intel
INTC
$455B
$1.75M 0.74%
12,601
-2,741
-18% -$89.8K
LHX icon
38
L3Harris
LHX
$51.6B
$1.73M 0.74%
7,491
-4,074
-35% -$880K
MDT icon
39
Medtronic
MDT
$109B
$1.72M 0.73%
14,256
+280
+2% +$23K
ICE icon
40
Intercontinental Exchange
ICE
$85.6B
$1.67M 0.71%
10,972
+316
+3% +$42.5K
EW icon
41
Edwards Lifesciences
EW
$49.6B
$1.66M 0.71%
14,361
+456
+3% +$40.4K
APD icon
42
Air Products & Chemicals
APD
$65.7B
$1.61M 0.69%
6,219
+100
+2% +$25.4K
SPGI icon
43
S&P Global
SPGI
$121B
$1.58M 0.67%
3,139
+85
+3% +$36.5K
BAC icon
44
Bank of America
BAC
$435B
$1.44M 0.61%
30,982
+1,959
+7% +$75.1K
CME icon
45
CME Group
CME
$96.3B
$1.35M 0.58%
6,679
+205
+3% +$42.4K
PG icon
46
Procter & Gamble
PG
$336B
$1.23M 0.52%
6,248
-420
-6% -$68.7K
DGRW icon
47
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$16.7B
$1.16M 0.49%
19,021
-150
-0.8% -$11.3K
MDLZ icon
48
Mondelez International
MDLZ
$79.5B
$1.11M 0.47%
2,644
-241
-8% -$16.5K
NSC icon
49
Norfolk Southern
NSC
$75.4B
$1M 0.43%
+167
New +$38.8K
VZ icon
50
Verizon
VZ
$195B
$913K 0.39%
11,664
-3,408
-23% -$137K

Similar funds

Central Valley Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Central Valley Advisors held 196 positions worth $234M, up 21% from $194M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Central Valley Advisors withdrew a net $18.9M in Q2 2024, closing 59 positions and reducing 54 holdings. Its most notable exit was Clorox, an estimated $1.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 7.3% a quarter earlier, followed by Technology and Financials.

Against the trend, Central Valley Advisors opened a new position in Innovator Growth-100 Power Buffer ETF - June worth $8.52M.

  • Central Valley Advisors's largest Q2 2024 buy was Innovator Growth-100 Power Buffer ETF - June: 286,727 shares worth $8.52M.
  • Central Valley Advisors added most to iShares Russell 2000 ETF in Q2 2024, an estimated $452K increase.
  • Central Valley Advisors's biggest Q2 2024 reduction was Cisco, cutting an estimated $1.3M.
  • Central Valley Advisors fully exited Clorox in Q2 2024, selling an estimated $1.5M.
  • Central Valley Advisors's ten largest holdings make up 47% of its $234M portfolio in Q2 2024.
  • Central Valley Advisors opened 39 new positions and closed 59 in Q2 2024.
  • Central Valley Advisors's portfolio value rose 21% quarter-over-quarter to $234M.

Based on Central Valley Advisors's 13F filing for Q2 2024, filed 12 Jul 2024.